• Chinese Tycoon Eyes $500M IPO of Luye Life Sciences' Clinic Arm biospace
    January 25, 2018
    Luye Life Sciences Group, run by acquisitive Chinese entrepreneur Liu Dianbo, is considering a Singapore initial public offering of its health-care services arm that could raise as much as $500 million, people with knowledge of the matter said.
PharmaSources Customer Service